Assignee
ORGENESIS INC
US·0 granted patents·16 pending applications·0 citations·filing 2019–2024
Top patents by PatentIndex Score
16 records- 0160US2024123043A1Pharmaceutical compositions comprising ranpirnaseORGENESIS INC·Filed 2022·Application pending·0 cites
- 0258US2024182852A1Cell-culture bioreactorsORGENESIS INC·Filed 2022·Application pending·0 cites
- 0357US2024358835A1Tumor infiltrating lymphocytes with increased metabolic activityORGENESIS INC·Filed 2022·Application pending·0 cites
- 0456US2023077429A1Cell-culture bioreactorORGENESIS INC·Filed 2021·Application pending·0 cites
- 0555US2024189425A1Chimeric antigen receptor with modified hinge and transmembrane domain and uses thereofORGENESIS INC·Filed 2024·Application pending·0 cites
- 0652US2022273774A1Prophylactic protection against viral infectionsORGENESIS INC·Filed 2022·Application pending·0 cites
- 0750US2021145960A1Prophylactic protection against viral infections, particularly hivORGENESIS INC·Filed 2020·Application pending·0 cites
- 0849US2023072523A1Process and system for acellular therapyORGENESIS INC·Filed 2021·Application pending·0 cites
- 0948US2025339502A1Ribonucleases for treating viral infectionsORGENESIS INC·Filed 2021·Application pending·0 cites
- 1048US2024350975A1System and method for ultrafiltration and concentration of biological components within a liquid suspensionORGENESIS INC·Filed 2022·Application pending·0 cites
- 1147US2021171915A1Three dimensional clusters of transdifferentiated cells, compositions and methods thereofORGENESIS INC·Filed 2019·Application pending·0 cites
- 1244US2023147602A1Ribonucleases for treating viral infectionsORGENESIS INC·Filed 2021·Application pending·0 cites
- 1343US2021052506A1Bioxomes particles, redoxomes, method and compositionORGENESIS INC·Filed 2019·Application pending·0 cites
- 1437US2022282195A1Mobile processing unit and laboratoriesORGENESIS INC·Filed 2022·Application pending·0 cites
- 1535US2025152697A1Autologous cell based sars-cov-2 vaccinesORGENESIS INC·Filed 2023·Application pending·0 cites
- 1635US2025152642A1Nasal anti-cancer therapiesORGENESIS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ORGENESIS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →